Human ADA2 deficiency is characterized by the absence of an intracellular hypoglycosylated form of adenosine deaminase 2

Autor/innen

  • L. Ehlers
  • M. Wouters
  • A. Hombrouck
  • B. Pillay
  • S. Delafontaine
  • G. Bucciol
  • M. Baggio
  • M. Dzhus
  • E. Francés Rabanal
  • A. Damerau
  • J. Neugebauer
  • F. Ebstein
  • M. Jacquemyn
  • L. De Somer
  • R. Schrijvers
  • S. Vanderschueren
  • D. Cassiman
  • M. Kirchner
  • P. Mertins
  • M.F. Mashreghi
  • T. Kallinich
  • D. Daelemans
  • P. Agostinis
  • L. Moens
  • I. Meyts

Journal

  • bioRxiv

Quellenangabe

  • bioRxiv

Zusammenfassung

  • Human deficiency of adenosine deaminase 2 (DADA2) is an autoinflammatory disease caused by pathogenic variants in ADA2 that lead to impaired deaminase activity. Recently, a lysosomal function of ADA2 has been proposed but an intracellular form of the protein has not yet been characterized. Here, we analyze protein expression of mutant ADA2 in human monocyte-derived macrophages from 10 DADA2 patients. We identify an intracellular low-molecular-weight (LMW) form of ADA2 that undergoes glycan trimming by α-mannosidases and is absent in DADA2 macrophages. Subcellular fractionation and immunofluorescence microscopy demonstrate that LMW-ADA2 is localized in the lysosomes. By overexpression of 34 ADA2 variants in HEK293T and U-937 cells, we show that absence of LMW-ADA2 strongly correlates with reduced deaminase activity and predicts variant pathogenicity. In conclusion, we describe a previously unreported intracellular hypoglycosylated form of ADA2 and establish the absence of this LMW-ADA2 as a cellular characteristic of DADA2. Thereby, we introduce a protein correlate of the recently described lysosomal form of ADA2.


DOI

doi:10.1101/2023.10.25.564037